Minerva Neurosciences (NERV) Other Accumulated Expenses (2013 - 2018)
Minerva Neurosciences' Other Accumulated Expenses was $5,217 in Q2 2018, down 85.2% from $35,270 a year earlier and down 59.7% from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Other Accumulated Expenses (2013 - 2018) Analysis & Trends
At the end of FY2017, Other Accumulated Expenses at Minerva Neurosciences came in at $20,508, down 58.6% from FY2016.
- Other Accumulated Expenses has now declined for three consecutive years, with a four-year compound annual growth rate of -4.1% (FY2013 to FY2017).
- In earlier years, Other Accumulated Expenses was $49,523 in FY2016 (-15.7%), $58,750 in FY2015 (-95.2%), $1.22 million in FY2014 and $24,276 in FY2013.
- The Q2 2018 figure marks the lowest quarterly Other Accumulated Expenses in data going back to Q4 2013.
- Compared with a year earlier, Other Accumulated Expenses has declined for 12 straight quarters, with an average decline of 43.9% over the last eight quarters.
- Across the past five years, year-over-year decline in Other Accumulated Expenses ran from 3.9% in Q3 2016 to 96.0% in Q1 2016.
- Per Business Quant data, NERV's Other Accumulated Expenses in the three quarters before Q2 2018 was $12,930 (Q1 2018), $20,508 (Q4 2017) and $27,954 (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Minerva Neurosciences | 154.91 Mn | 154.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 5,217.00 |
| Mar 31, 2018 | 12,930.00 |
| Dec 31, 2017 | 20,508.00 |
| Sep 30, 2017 | 27,954.00 |
| Jun 30, 2017 | 35,270.00 |
| Mar 31, 2017 | 42,459.00 |
| Dec 31, 2016 | 49,523.00 |
| Sep 30, 2016 | 56,463.00 |
| Jun 30, 2016 | 58,750.00 |
| Mar 31, 2016 | 58,750.00 |
| Dec 31, 2015 | 58,750.00 |
| Sep 30, 2015 | 58,750.00 |
| Jun 30, 2015 | 1.08 Mn |
| Mar 31, 2015 | 1.46 Mn |
| Dec 31, 2014 | 1.22 Mn |
| Sep 30, 2014 | 1.39 Mn |
| Dec 31, 2013 | 24,276.00 |
API Access
Minerva Neurosciences Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();